Carisma Therapeutics
CARM
CARM was delisted on the 10th of October, 2025.
7 hedge funds and large institutions have $67K invested in Carisma Therapeutics in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 28 closing their positions.
3.62% less ownership
Funds ownership: 7.36% → 3.75% (-3.6%)
79% less funds holding
Funds holding: 33 → 7 (-26)
92% less capital invested
Capital invested by funds: $843K → $67K (-$776K)
93% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$10K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$4.89K |
| 3 |
UBP
Union Bancaire Privee
Geneva 1,
Switzerland
|
+$63 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$96K |
| 2 |
BlackRock
New York
|
-$92.3K |
| 3 |
Renaissance Technologies
New York
|
-$80.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$68.7K |
| 5 |
State Street
Boston,
Massachusetts
|
-$23.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| – | -$252 | -921 | Closed |
|
27
BNP Paribas Financial Markets
Paris,
France
| – | -$95 | -347 | Closed |
|
|
CWA
28
Carolina Wealth Advisors
Myrtle Beach,
South Carolina
| – | -$41 | -150 | Closed |
|
29
Osaic Holdings
Scottsdale,
Arizona
| – | -$29 | -142 | Closed |
|
|
SS
30
SBI Securities
Tokyo,
Japan
| – | -$29 | -107 | Closed |
|
|
MWA
31
Medallion Wealth Advisors
Farmington,
Connecticut
| – | -$27 | -100 | Closed |
|
32
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$13 | -50 | Closed |
|
|
HI
33
Harbour Investments
Madison,
Wisconsin
| – | -$10 | -37 | Closed |
|
34
Jones Financial Companies
Des Peres,
Missouri
| – | -$5 | -16 | Closed |
|
CARM Hedge Fund Activity: Q4 2025 in Review
7 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q4 2025, worth a combined $67K — down 92% from $843K a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CARM and 2 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $10K. The largest seller was Vanguard Group, exiting entirely with an estimated $96K sold.
- 7 institutional investors held Carisma Therapeutics (CARM) as of Q4 2025, down from 33 in Q3 2025.
- Funds reported $67K of Carisma Therapeutics stock for Q4 2025, down 92% quarter-over-quarter.
- 2 funds opened new Carisma Therapeutics positions in Q4 2025 and 28 closed out, a net change of -26 holders.
- The largest Carisma Therapeutics buyer in Q4 2025 was XTX Topco, an estimated $10K added.
- The largest Carisma Therapeutics seller in Q4 2025 was Vanguard Group, an estimated $96K sold.
Based on aggregated 13F filings for Q4 2025.